KRONOS BIO
Kronos Bio focuses on the research and development of first-in-class therapies that modulate historically recalcitrant cancer targets. It develops therapies that modulate historically undruggable targets. The company leverages deep capabilities in high-throughput small-molecule microarrays (SMM), targeted protein degradation, and cancer biology in order to identify potent and selective compounds against transcription factors and other central drivers of oncogenic signaling.
KRONOS BIO
Industry:
Biotechnology Chemical Therapeutics
Founded:
2017-01-01
Address:
San Mateo, California, United States
Country:
United States
Website Url:
http://www.kronosbio.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
278 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Apple Mobile Web Clips Icon WordPress Font Awesome Domain Not Resolving Wordpress Plugins
Similar Organizations
1859
1859 is a biotechnology company focusing on the discovery and development of next-generation therapeutics.
Acrivon Therapeutics
Acrivon Therapeutics is a precision oncology therapeutics company specializing in drug development through early clinical treatment success.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Fulcrum Therapeutics
Fulcrum Therapeutics is a biotechnology company that develops new medicines to treat patients with rare genetic diseases.
Hookipa Pharma
Hookipa is a clinical stage biotech company developing best-in-class active immunization therapies for infectious diseases and oncology.
Spero Therapeutics
Spero Therapeutics develops therapeutics for treatment of gram-negative infections.
Sunshine Biopharma
Sunshine Biopharma focuses on the research, development, and commercialization of drugs for the treatment of various forms of cancer.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Fidelity Management and Research Company
Fidelity Management and Research Company investment in Private Equity Round - Kronos Bio
Vida Ventures
Vida Ventures investment in Private Equity Round - Kronos Bio
Commodore Capital
Commodore Capital investment in Private Equity Round - Kronos Bio
Woodline Partners
Woodline Partners investment in Private Equity Round - Kronos Bio
Nextech Invest
Nextech Invest investment in Private Equity Round - Kronos Bio
Invus
Invus investment in Private Equity Round - Kronos Bio
GV
GV investment in Private Equity Round - Kronos Bio
T. Rowe Price
T. Rowe Price investment in Private Equity Round - Kronos Bio
BlackRock
BlackRock investment in Private Equity Round - Kronos Bio
Surveyor Capital
Surveyor Capital investment in Private Equity Round - Kronos Bio
Key Employee Changes
Official Site Inspections
http://www.kronosbio.com Semrush global rank: 4.57 M Semrush visits lastest month: 2.27 K
- Host name: a2aa9ff50de748dbe.awsglobalaccelerator.com
- IP address: 15.197.148.33
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Kronos Bio"
About - Kronos Bio
Kronos Bio, Inc. 301 Binney Street 2nd Floor East Cambridge, MA 02142 +1 (650) 781-5200See details»
Company - Kronos Bio
About Us We are a clinical-stage biopharmaceutical company discovering and developing therapeutics that target the deregulated transcription that causes cancer and autoimmune diseases. We find meaning in bringing forward …See details»
Kronos Bio - Crunchbase Company Profile & Funding
Kronos Bio focuses on the research and development of first-in-class therapies that modulate historically recalcitrant cancer targets. It develops therapies that …See details»
Kronos Bio Enters into Agreement to Be Acquired by Concentra ...
4 days ago CAMBRIDGE, Mass., May 01, 2025 (GLOBE NEWSWIRE) -- Kronos Bio, Inc. ("Kronos Bio") (Nasdaq: KRON), a biotechnology company that has been developing small …See details»
Kronos Bio Implements New Leadership Structure to …
Jan 25, 2024 Company eliminates three executive officer roles and appoints new Executive Leadership teamSAN MATEO, Calif., and CAMBRIDGE, Mass., Jan. 25, 2024 (GLOBE NEWSWIRE) -- Kronos Bio, Inc. (Nasdaq: KRON ...See details»
Kronos Bio Reports Third Quarter 2024 Financial Results and …
Sep 30, 2024 [email protected] . Contact. Headquarters. Kronos Bio, Inc. 1300 So. El Camino Real Suite 400 San Mateo, CA 94402 +1 (650) 781-5200. Research Facility. Kronos …See details»
Kronos Bio - LinkedIn
Kronos Bio is a clinical-stage biopharmaceutical company developing therapeutics that target the dysregulated transcription that causes cancer and other serious diseases.See details»
Kronos Bio, Inc. Company Profile | San Mateo, CA | Competitors ...
Find company research, competitor information, contact details & financial data for Kronos Bio, Inc. of San Mateo, CA. Get the latest business insights from Dun & Bradstreet.See details»
Working At Kronos Bio: Company Overview and Culture - Zippia
Www.kronosbio.com. Organization Type. Public. CEO. Norbert W. Bischofberger. Social Media. Kronos Bio is dedicated to the research and development of first-in-class therapies that …See details»
Kronos Bio - Kronos Bio
Our Vision Create a world where no life is cut short by cancer or other serious diseases. Our Science Medicines that reach traditionally hard-to-reach targets. Transcription factors have …See details»
Kronos Bio, Inc. - AnnualReports.com
Kronos Bio is a biopharmaceutical company that is advancing two investigational compounds in clinical trials for patients with cancer. The company is developing the CDK9 inhibitor KB-0742 as a treatment for MYC-amplified solid tumors …See details»
Kronos Bio Company Profile | Management and Employees List
Kronosbio. Primary Industries. Manufacturing Pharmaceuticals. Contact Information. Headquarters. 1300 S El Camino Real Ste 400, San Mateo, California, 94402, United States …See details»
Kronos Bio Strengthens Senior Management Team with New …
Oct 24, 2019 [email protected]. Media Contact: Sheryl Seapy W2O pure +1 213-262-9390 [email protected]. Contact. Headquarters. Kronos Bio, Inc. 1300 So. El …See details»
Kronos Bio - Work in biotech
Kronos Bio is developing therapeutics that target dysregulated transcription that underpins most human diseases. Individual transcription factors, which dictate expression of a subset of …See details»
Kronos Bio - Craft
Oct 29, 2024 Kronos Bio has 1 employees across 3 locations and $6.29 m in annual revenue in FY 2023. See insights on Kronos Bio including office locations, competitors, revenue, …See details»
Deborah Knobelman, Ph.D. - Kronos Bio
Kronos Bio, Inc. 301 Binney Street 2nd Floor East Cambridge, MA 02142 +1 (650) 781-5200See details»
Kronos Bio - Company Profile & Staff Directory - ContactOut
Kronos Bio is a clinical-stage biopharmaceutical company developing therapeutics that target the dysregulated transcription that causes cancer and other serious diseases. Our pipeline …See details»
Science - Kronos Bio
Our Science Deregulated transcription is a hallmark of cancer and autoimmune diseases. Kronos Bio is focused on developing medicines that target deregulated transcription factor activity. In …See details»
Kronos Bio Enters into Agreement to Be Acquired by
4 days ago CAMBRIDGE, Mass., May 01, 2025 (GLOBE NEWSWIRE) -- Kronos Bio, Inc. ("Kronos Bio") (Nasdaq: KRON), a biotechnology company that has been developing small …See details»
Kronos Bio Enters into Agreement to Be Acquired by Concentra ...
4 days ago For more information, visit https://www.kronosbio.com. Advisors Goodwin Procter LLP is acting as legal counsel to Kronos Bio and Leerink Partners is acting as sole financial …See details»